Precept Management LLC Reata Pharmaceuticals Inc Transaction History

Precept Management LLC

  • $125 Million
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$102.03 - $184.62 $2.14 Million - $3.88 Million
-21,000 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$93.53 - $163.34 $935,300 - $1.63 Million
-10,000 Reduced 32.26%
21,000 $2.05 Million
Q2 2020

Aug 14, 2020
BUY
$126.3 - $176.56 $2.65 Million - $3.71 Million
21,000 Added 210.0%
31,000 $4.84 Million
Q1 2020

May 15, 2020
BUY
$124.16 - $247.74 $248,320 - $495,480
2,000 Added 25.0%
10,000 $1.44 Million
Q4 2019

Feb 14, 2020
BUY
$74.57 - $217.92 $596,560 - $1.74 Million
8,000 New
8,000 $1.64 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Precept Management LLC Portfolio

Follow Precept Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Precept Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Precept Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email